SonALAsense, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM (NCT05370508) | SonALAsense, Inc. | 2023-02-06 |
| A Phase 2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Patients with DIPG (NCT05123534) | SonALAsense, Inc. | 2022-08-12 |
Track SonALAsense, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.